SELLAS Life Sciences Group, Inc. (SLS)
9.675
-0.48
(-4.73%)
USD |
NASDAQ |
Oct 30, 16:00
9.66
-0.02
(-0.16%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash and Short Term Investments (Annual) : 71.89M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 71.89M |
| December 31, 2024 | 13.99M |
| December 31, 2023 | 2.63M |
| December 31, 2022 | 17.22M |
| December 31, 2021 | 21.46M |
| December 31, 2020 | 35.40M |
| December 31, 2019 | 7.377M |
| December 31, 2018 | 5.451M |
| December 31, 2017 | 12.75M |
| December 31, 2016 | 6.047M |
| December 31, 2015 | 30.13M |
| Date | Value |
|---|---|
| December 31, 2014 | 23.85M |
| December 31, 2013 | 47.99M |
| December 31, 2012 | 35.59M |
| December 31, 2011 | 11.53M |
| December 31, 2010 | 6.891M |
| December 31, 2009 | 5.684M |
| December 31, 2008 | 9.856M |
| December 31, 2007 | 11.72M |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| ImmunityBio, Inc. | 242.82M |
| TG Therapeutics, Inc. | 141.97M |
| Capricor Therapeutics, Inc. | 318.13M |
| Relay Therapeutics, Inc. | 554.52M |